| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/23/2002 | EP1173763A1 Methods and compositions for determining latent viral load |
| 01/23/2002 | EP1173762A1 Method for diagnosing diseases and pathological states |
| 01/23/2002 | EP1173760A1 Encoding of microcarriers |
| 01/23/2002 | EP1173623A1 Solid medium and process for the storage and rapid purification of nucleic acid |
| 01/23/2002 | EP1173622A2 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry |
| 01/23/2002 | EP1173621A1 Comparative fluorescence hybridization to oligonucleotide microarrays |
| 01/23/2002 | EP1173620A1 Biochip and method for making same |
| 01/23/2002 | EP1173619A2 Identification of candida albicans essential fungal specific genes and use thereof in antifungal drug discovery |
| 01/23/2002 | EP1173617A1 Method for detecting by dhplc a difference of dna genotype and/or sequence |
| 01/23/2002 | EP1173616A1 Method of scanning for improved dynamic range |
| 01/23/2002 | EP1173615A2 System and method for screening of nasopharyngeal carcinoma |
| 01/23/2002 | EP1173613A2 Methods of detecting microorganism using immobilized probes |
| 01/23/2002 | EP1173612A2 METHOD FOR THE DETECTION AND/OR ANALYSIS, BY MEANS OF PRIMER EXTENSION TECHNIQUES, OF SINGLE NUCLEOTIDE POLYMORPHISMS IN RESTRICTION FRAGMENTS, IN PARTICULAR IN AMPLIFIED RESTRICTION FRAGMENTS GENERATED USING AFLP$m(3) |
| 01/23/2002 | EP1173611A1 Methods for determination of single nucleic acid polymorphisms using a bioelectronic microchip |
| 01/23/2002 | EP1173610A2 Method for the amplification of hla class i alleles |
| 01/23/2002 | EP1173609A2 Genetic analysis |
| 01/23/2002 | EP1173608A1 Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2 |
| 01/23/2002 | EP1173607A1 Method for the determination of disaccharidases and kit therefor |
| 01/23/2002 | EP1173604A1 Methods, compositions and kits for biological indicator of sterilization |
| 01/23/2002 | EP1173603A2 Biological indicators for validating a prion sterilization-process |
| 01/23/2002 | EP1173591A2 Pesticidal fusions |
| 01/23/2002 | EP1173590A2 Zymogen activation system |
| 01/23/2002 | EP1173587A1 Dsp-10 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173586A1 Dsp-8 dual-specificity map kinase phosphatase |
| 01/23/2002 | EP1173580A1 Herbicide resistant plants |
| 01/23/2002 | EP1173573A1 Method for down-regulating il5 activity |
| 01/23/2002 | EP1173571A2 Human ion channel proteins |
| 01/23/2002 | EP1173569A1 Synthetic signalling molecules |
| 01/23/2002 | EP1173566A2 Human membrane-associated proteins |
| 01/23/2002 | EP1173563A1 Compositions and methods for the treatment of tumour |
| 01/23/2002 | EP1173562A2 Inhibition of histone deacetylase |
| 01/23/2002 | EP1173561A2 Non-invasive method for detecting target rna |
| 01/23/2002 | EP1173560A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 01/23/2002 | EP1173557A1 Method for encapsulating macromolecules and/or particles and use thereof |
| 01/23/2002 | EP1173555A1 Method and kit for indicating the level of bad breath |
| 01/23/2002 | EP1173552A2 Carbohydrate-modifying enzymes |
| 01/23/2002 | EP1173548A2 Materials and methods relating to neuronal development |
| 01/23/2002 | EP1173479A1 49 human secreted proteins |
| 01/23/2002 | EP1173478A1 49 human secreted proteins |
| 01/23/2002 | EP1173477A1 49 human secreted proteins |
| 01/23/2002 | EP1173465A1 Novel human voltage-gated potassium channel |
| 01/23/2002 | EP1173462A1 50 human secreted proteins |
| 01/23/2002 | EP1173456A1 Secreted proteins and nucleic acids encoding them |
| 01/23/2002 | EP1173202A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 01/23/2002 | EP1173196A1 New use of a substance in pns |
| 01/23/2002 | EP1173195A2 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 01/23/2002 | EP1173189A1 Asialocytokines and treatment of liver disease |
| 01/23/2002 | EP1049744B1 Asymmetric cyanine dye quenchers |
| 01/23/2002 | EP0968303A4 Method and system for performing a binding assay |
| 01/23/2002 | EP0944736A4 Methods and compositions for the diagnosis of extraesophageal gastric reflux |
| 01/23/2002 | EP0920631B1 Method for identifying compounds affecting rna/rna binding protein interactions |
| 01/23/2002 | EP0884947A4 Dna vaccination for induction of suppressive t cell response |
| 01/23/2002 | EP0846124B1 Chemical, biochemical and biological processing in thin films |
| 01/23/2002 | EP0840802B1 Method of sequencing by oligomer hybridisation |
| 01/23/2002 | CN2473212Y Biological chip analying instrument |
| 01/23/2002 | CN2473211Y Protein chip reactor |
| 01/23/2002 | CN1332805A Multiplex amplification of short tandem repeat loci |
| 01/23/2002 | CN1332804A Means and methods for monitoring nucleoside reverse transcriptase inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS |
| 01/23/2002 | CN1332801A Connective tissue growth factor (CTGF) and methods of use |
| 01/23/2002 | CN1332798A Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis |
| 01/23/2002 | CN1332796A Method for separating viral particles |
| 01/23/2002 | CN1332748A Isolated nucleic acid molecules which encodt T cell inducible factors (TIFs), proteins encoded, and uses thereof |
| 01/23/2002 | CN1332375A Method for differentiation and enrichment of cell specific target structure |
| 01/23/2002 | CN1332245A Morbillivirus L4 strain fusion protein gene |
| 01/23/2002 | CN1332244A Morbillivirus L4 strain hemagglutinin gene |
| 01/23/2002 | CN1332239A Hepatitis B virus complete-genome polymerase chimera and its construction process and application |
| 01/23/2002 | CN1332174A Optical information gene material and its application in gene chip technology |
| 01/22/2002 | US6340740 An isolated polypeptide involved in modulating apoptotis; therapy for acquired immunodeficiency syndrome (aids), nervous system disorders and ischemic injury |
| 01/22/2002 | US6340599 Terbium, dysprosium, samarium, osmium, or ruthenium complex with unsaturated oxyaryl compound |
| 01/22/2002 | US6340597 Electroconductive powder, chemical mediator, absorber, solid binding maker; biocatalyst incorporated into bulk of composite transducer |
| 01/22/2002 | US6340577 Protein fragments for use in protein targeting |
| 01/22/2002 | US6340576 Nucleic acid molecules related to card-4L and CARD-4S |
| 01/22/2002 | US6340573 Detecting enzymatic activity of enzymes characterized in a substrate containing two molecules with nonchromogenic labels, each molecule specific for two different enzymes, then once released they react and form a chromogenic molecule |
| 01/22/2002 | US6340572 The kit consist of a carrier means adapted with two containers separated by chromatography paper, the first container has the luminescent biological agent, the second contains the diluent for the luminescent biological agent |
| 01/22/2002 | US6340570 Detection and characterization of microorganisms |
| 01/22/2002 | US6340568 Method for detecting and classifying nucleic acid hybridization |
| 01/22/2002 | US6340567 Modeling a restriction map in the form of a vector from dataof individual dna molecules, finding a candidate restriction map referred to as a hypothesis map, ranking the maps according to the likelihood of being correct |
| 01/22/2002 | US6340566 Detection and quantitation of single nucleotide polymorphisms, DNA sequence variations, DNA mutations, DNA damage and DNA mismatches |
| 01/22/2002 | US6340565 Determining signal transduction pathways |
| 01/22/2002 | US6340563 Obtaining a histological tissue sample and analyzing under the microscope to target and select a sample that has pathological characteristics, obtaining dna sequences from the target sample, amplifying the dna and detecting mutations |
| 01/22/2002 | US6340459 Administering to agent capable of inhibiting interaction between cd40 ligand and the cells to inhibit activation of the cells in therapy of reperfusion injury, in an non-transplant recipient |
| 01/22/2002 | US6340428 Device and method for determining the concentration of a substrate |
| 01/22/2002 | US6340421 Microelectrogravimetric method for plating a biosensor |
| 01/22/2002 | CA2149333C Eck receptor ligands |
| 01/22/2002 | CA2038398C Dna encoding a growth factor specific for epithelial cells |
| 01/20/2002 | CA2312269A1 A dna marker for cattle growth |
| 01/18/2002 | CA2349743A1 Diagnostic assay |
| 01/17/2002 | WO2002004957A2 Fourier transform mass spectrometry of complex biological samples |
| 01/17/2002 | WO2002004956A2 Method of identifying conformation-sensitive binding peptides and uses thereof |
| 01/17/2002 | WO2002004953A2 Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers |
| 01/17/2002 | WO2002004952A2 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 01/17/2002 | WO2002004948A2 Distinguishing molecular forms |
| 01/17/2002 | WO2002004946A2 Methods for identifying combinations of drugs |
| 01/17/2002 | WO2002004943A2 Electrophysiology configuration suitable for high throughput screening of compounds for drug discovery |
| 01/17/2002 | WO2002004928A1 Method for detecting polynucleotide sequences |
| 01/17/2002 | WO2002004924A1 Method for the examination of cells in a culture medium |
| 01/17/2002 | WO2002004686A2 Detecting methylated cytosine in polynucleotides |
| 01/17/2002 | WO2002004684A1 Role of pph1 gene in pulmonary hypertension |
| 01/17/2002 | WO2002004683A2 Method of detecting an increased susceptibility to breast cancer |
| 01/17/2002 | WO2002004682A2 Polymorphisms in a diacylglycerol acyltransferase gene, and methods of use thereof |